Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SABBOBCATon Jun 08, 2021 11:32am
105 Views
Post# 33347789

RE:RE:RE:RE:Who was notified of the webinar?

RE:RE:RE:RE:Who was notified of the webinar?

SPCEO, I agree with you often, but the wait and see approach is not valid in this instance. If they do not have an aduciance for the webinar, then what is the point? As shareholders, we should want the largest audiance possible istening to this news! Why are they not promoting it? They put a PR out to tell the world that they hired a new HR leader, but they arent going to put one out to tell the world they have an update on their pivitol Cancer trial? I don't know about you, but my schedule is already filling up fast that week, so if they want people to tune in during a business day then they had better goive advanced notice so people can make the time. It is not rocket science!

TH is a tree in the in the forrest of publicly listed companies, if they drop big news but no one is around, does it make any difference at all?

 


SPCEO1 wrote: I think it is safe to say that TH has proven pretty conclusively that they are not very good at this aspect of their business. But give them credit, they have recognized it and hired LSA to sort it out as well as committed to hiring a new board member with capital markets experience. Like you I am alarmed when I see a continuation of the tiny trading volume trend each day but I say let's see how they handle this meeting in the next two weeks and the weeks after it. Hopefully, we will see soon they have upped their game in this area. They are going to have some new info on their critical cancer phase I trial, which should be able to be leveraged to attract investor attention and they have a firm who specializes in drawing attention to just that sort of data working for them. It may just work out. While TH's history in IR does not give anyone any confidence, it is kind of a perfect low expectations set-up where we could all be surprised at a new professionalism being evident. 
 

SABBOBCAT wrote:

I get that they are paying LSA to run this and get TH infront of new eyes, but you'd think that TH management would have learnt from the prior disasterous General NASH presentation that a public PR just a few days prior to the event is not the way to go. We are now inside of two weeks from the presentation, why not PR to build momentup for TH? I would be surprised if it is LSA putting up a stink as it wouuld just be more PR for them. 

Movie studios know and understand the value of marketing prior to relase to build anticipation and momentm. It is a tried and true path to follow, yet TH is taking the approach that they are "Exclusive" and are doing a one night, invitation only event, but that only works if you have a reputation for success. Why not PR now with a reminder the week of or day before? Stop being so damn tight fisted with the information!!!!

 
 

SPCEO1 wrote: LSA is primarily responsible for spreading the word through their distribution network. When I missed LSA's e-mail notification about this webinar, Leah forwarded it to me and others. I suspect that TH will announce it as well closer to the actual date. But they are paying LSA to bring new eyes to TH's stock and if this is going to be beneficial for the stock, it will be because LSA got the needed eyeballs to the webinar and because TH's team impresses those folks with their presentation.

 

longterm56 wrote: Anyone have any clues on how they are publicizing this upcoming webinar?  I'm registered with THTX for e-mail alerts of any press releases, news, events.  It sure seems that the webinar would fall into one of those categories yet I have not received anything.  Is this a "by invitation only" event?  Seems you would want this known far and wide ...

  -LT

 

 

 




<< Previous
Bullboard Posts
Next >>